These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 8383096

  • 21. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
    Liu XP, Fan SR, Peng YT, Zhang HP.
    J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
    [Abstract] [Full Text] [Related]

  • 22. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
    Diaz MC, Camponovo R, Araya I, Cerda A, Santander MP, Carrillo-Muñoz AJ.
    Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
    [Abstract] [Full Text] [Related]

  • 23. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S, Nierebińska E, Gwieździński Z.
    Przegl Dermatol; 1989 Jun; 76(5-6):405-9. PubMed ID: 2561925
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
    Theill L, Dudiuk C, Morano S, Gamarra S, Nardin ME, Méndez E, Garcia-Effron G.
    Rev Argent Microbiol; 2016 Jun; 48(1):43-9. PubMed ID: 26922471
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Vulvovaginal candidiasis and sensitivity of pathogens to antimycotics].
    Sojáková M, Liptajová D, Simoncicová M, Borovský M, Subík J.
    Ceska Gynekol; 2003 Jan; 68(1):24-9. PubMed ID: 12708111
    [Abstract] [Full Text] [Related]

  • 28. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
    Odds FC, Webster CE, Abbott AB.
    J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418
    [Abstract] [Full Text] [Related]

  • 29. Azole resistance in Candida albicans.
    Ryley JF, Wilson RG, Barrett-Bee KJ.
    Sabouraudia; 1984 Aug; 22(1):53-63. PubMed ID: 6322363
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F, Benderdouche M, Sednaoui P.
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [Abstract] [Full Text] [Related]

  • 33. Effects of pentamidine alone and in combination with ketoconazole or itraconazole on the growth of Candida albicans.
    St-Germain G.
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2304-6. PubMed ID: 1965104
    [Abstract] [Full Text] [Related]

  • 34. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
    Nagashima M, Yamagishi Y, Mikamo H.
    J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
    [Abstract] [Full Text] [Related]

  • 35. Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans.
    Consolaro ME, Albertoni TA, Svidzinski AE, Peralta RM, Svidzinski TI.
    Mycopathologia; 2005 Jun; 159(4):501-7. PubMed ID: 15983735
    [Abstract] [Full Text] [Related]

  • 36. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Odds FC, Cockayne A, Hayward J, Abbott AB.
    J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
    [Abstract] [Full Text] [Related]

  • 37. Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.
    Wang FJ, Zhang D, Liu ZH, Wu WX, Bai HH, Dong HY.
    Chin Med J (Engl); 2016 May 20; 129(10):1161-5. PubMed ID: 27174323
    [Abstract] [Full Text] [Related]

  • 38. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
    García Heredia M, García SD, Copolillo EF, Cora Eliseth M, Barata AD, Vay CA, de Torres RA, Tiraboschi N, Famiglietti AM.
    Rev Argent Microbiol; 2006 May 20; 38(1):9-12. PubMed ID: 16784126
    [Abstract] [Full Text] [Related]

  • 39. Initial management of recurrent vulvovaginal candidiasis with oral ketoconazole and topical clotrimazole.
    Sobel JD, Schmitt C, Stein G, Mummaw N, Christensen S, Meriwether C.
    J Reprod Med; 1994 Jul 20; 39(7):517-20. PubMed ID: 7966041
    [Abstract] [Full Text] [Related]

  • 40. Comparison of vaginal ointment of honey and clotrimazole for treatment of vulvovaginal candidiasis: A random clinical trial.
    Banaeian S, Sereshti M, Rafieian M, Farahbod F, Kheiri S.
    J Mycol Med; 2017 Dec 20; 27(4):494-500. PubMed ID: 28760590
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.